Skip to main content
. 2023 Aug 15;14:1210756. doi: 10.3389/fendo.2023.1210756

Table 2.

Metabolic outcomes, 12 months of follow-up.

One-year follow-up period
Metrics Quarter 1 Quarter 2 Quarter 3 Quarter 4 Avg ± SD
Sensor glucose outcomes
Avg SG (mg/dL) 132.3 ± 7.1 133 ± 9.8 137.6 ± 11.8 136.3 ± 10.2 134.8 ± 9.9
SD of SG (mg/dL) 41.2 ± 5.1 41.3 ± 5.5 41.5 ± 7.0 41.4 ± 7.3 41.4 ± 6.2
GMI (%) 6.5 ± 0.2 6.5 ± 0.2 6.6 ± 0.3 6.6 ± 0.2 6.5 ± 0.2
% of time SG <54 mg/dL 0.4 ± 0.4 0.4 ± 0.5 0.2 ± 0.3 0.3 ± 0.3 0.3 ± 0.4
% of time SG <70 mg/dL 2.1 ± 1.4 2.1 ± 1.5 1.4 ± 1.3 1.5 ± 1.2 1.7 ± 1.4
% of time SG 70–180 mg/dL 84.8 ± 4.4 84.1 ± 5.3 83.2 ± 6.5 84.0 ± 6.4 84.0 ± 5.6
%of time SG >180 mg/dL 11.4 ± 3.5 12.0 ± 5.0 13.3 ± 5.7 12.3 ± 5.2 12.3 ± 4.9
% of time SG >250 mg/dL 1.4 ± 1.0 1.5 ± 1.1 1.9 ± 1.7 2.0 ± 1.7 1.7 ± 1.4

SG, sensor glucose; SD, standard deviation; GMI, Glucose Management Indicator; N, number; Avg, average.

Values are presented by Mean ± SD (Median).